Spero Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Spero Therapeutics has a total shareholder equity of $65.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $135.2M and $69.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$76.29m |
| Equity | US$65.51m |
| Total liabilities | US$69.65m |
| Total assets | US$135.16m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2HA's short term assets ($131.6M) exceed its short term liabilities ($49.1M).
Long Term Liabilities: 2HA's short term assets ($131.6M) exceed its long term liabilities ($20.6M).
Debt to Equity History and Analysis
Debt Level: 2HA is debt free.
Reducing Debt: 2HA had no debt 5 years ago.
Debt Coverage: 2HA has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 2HA has no debt, therefore coverage of interest payments is not a concern.